ARE LIPID ABNORMALITIES RELIABLE CARDIOVASCULAR RISK-FACTORS IN DIALYSIS PATIENTS

被引：9

作者：

BERGESIO, F

CIUTI, R

SALVADORI, M

GALLI, GA

MONZANI, G

BERTONI, E

SALERNO, A

FRIZZI, V

机构：

[1] CAREGGI REG HOSP,DEPT NEPHROL & DIALYSIS,FLORENCE,ITALY

[2] NEW HOSP SAN GIOVANNI DI DIO,DEPT CLIN CHEM,I-50137 FLORENCE,ITALY

来源：

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 1989年 / 12卷 / 11期

关键词：

D O I：

10.1177/039139888901201102

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

页码：677 / 682

页数：6

共 25 条

[1] SERUM APOLIPOPROTEIN PROFILE OF PATIENTS WITH CHRONIC-RENAL-FAILURE [J].

ATTMAN, PO ;

ALAUPOVIC, P ;

GUSTAFSON, A .

KIDNEY INTERNATIONAL, 1987, 32 (03) :368-375

[2]

AVOGARO P, 1979, LANCET, V1, P901

[3]

BAGHDADE JD, 1977, NEW ENGL J MED, V296, P1436

[4]

BRADBY GVH, 1978, LANCET, V2, P1271

[5] ACCELERATED ATHEROSCLEROSIS IN CHRONIC-DIALYSIS PATIENTS - ANOTHER LOOK [J].

BURKE, JF ;

FRANCOS, GC ;

MOORE, LL ;

CHO, SY ;

LASKER, N .

NEPHRON, 1978, 21 (04) :181-185

[6] HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].

CASTELLI, WP ;

DOYLE, JT ;

GORDON, T ;

HAMES, CG ;

HJORTLAND, MC ;

HULLEY, SB ;

KAGAN, A ;

ZUKEL, WJ .

CIRCULATION, 1977, 55 (05) :767-772

[7]

CHAN MK, 1980, LANCET, V1, P591

[8] LIPID ABNORMALITIES IN UREMIA, DIALYSIS, AND TRANSPLANTATION [J].

CHAN, MK ;

VARGHESE, Z ;

MOORHEAD, JF .

KIDNEY INTERNATIONAL, 1981, 19 (05) :625-637

[9] MORTALITY RISK-FACTORS IN PATIENTS TREATED BY CHRONIC-HEMODIALYSIS - REPORT OF THE DIAPHANE COLLABORATIVE STUDY [J].

DEGOULET, P ;

LEGRAIN, M ;

REACH, I ;

AIME, F ;

DEVRIES, C ;

ROJAS, P ;

JACOBS, C .

NEPHRON, 1982, 31 (02) :103-110

[10] ANALYSIS OF CARDIOVASCULAR RISK-FACTORS IN CHRONIC-HEMODIALYSIS PATIENTS WITH SPECIAL ATTENTION TO THE HYPERLIPOPROTEINEMIAS [J].

HAHN, R ;

OETTE, K ;

MONDORF, H ;

FINKE, K ;

SIEBERTH, HG .

ATHEROSCLEROSIS, 1983, 48 (03) :279-288

← 1 2 3 →